Literature DB >> 35969323

Ca2Fe2O5 powder antifungal activity to the Candida utilis culture upon its growth.

Svetlana Vihodceva1, Vasily Bankovskis2, Olga Muter3, Andris Šutka4.   

Abstract

This study reports the impact of Ca2Fe2O5 porous powder on the yeast Candida utilis-as a fungal model-at different phases of growth, i.e., early exponential (6 h), mid-log (11 h), and stationary (17 h) phases. Ca2Fe2O5 inhibited the cell growth in a time-dependent manner. After 120 min incubation, the fungicidal activity of porous powder was observed, i.e., log reduction of 2.81 and 2.58 for 11 and 17 h cultures, respectively, reaching the maximum of 4 log reduction after 7 days. Nevertheless, the 6 h culture of C. utilis showed enhanced resistance to Ca2Fe2O5 with a ≤ 0.4 log reduction during the 7 days exposure. Our results not only showed that Ca2Fe2O5 has the potential to effectively eliminate the C. utilis cell growth but also indicated the importance of the yeast culture physiological state for resistance to Ca2Fe2O5. To the best of our knowledge, this is the first study that evaluated the fungicidal activity of Ca2Fe2O5 porous powder on C. utilis and the impact of the C. utilis phase of growth on the cell susceptibility.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Antifungal; Ca-Fe oxide; Candida utilis; Growth kinetics; Yeast; fungi

Mesh:

Substances:

Year:  2022        PMID: 35969323     DOI: 10.1007/s10534-022-00429-x

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   3.378


  21 in total

1.  Chronic urinary tract infection due to Candida utilis.

Authors:  K C Hazen; G W Theisz; S A Howell
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

2.  Candida utilis candidaemia in neonatal patients.

Authors:  Amarela Lukić-Grlić; Emilija Mlinarić-Missoni; Ivančica Škarić; Verica Važić-Babić; Ivan-Krešimir Svetec
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

3.  Raman micro-spectroscopy monitoring of cytochrome c redox state in Candida utilis during cell death under low-temperature plasma-induced oxidative stress.

Authors:  Zhu Chen; Jinghua Liu; Lijiao Tian; Qianqian Zhang; Yong Guan; Liang Chen; Gang Liu; Han-Qing Yu; Yangchao Tian; Qing Huang
Journal:  Analyst       Date:  2020-04-20       Impact factor: 4.616

4.  Synthesis, characterization of ZnO-chitosan nanocomposites and evaluation of its antifungal activity against pathogenic Candida albicans.

Authors:  S H S Dananjaya; R Saravana Kumar; Minyang Yang; Chamilani Nikapitiya; Jehee Lee; Mahanama De Zoysa
Journal:  Int J Biol Macromol       Date:  2017-11-10       Impact factor: 6.953

5.  Candida albicans biofilms produce antifungal-tolerant persister cells.

Authors:  Michael D LaFleur; Carol A Kumamoto; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2006-08-21       Impact factor: 5.191

Review 6.  Stationary phase in yeast.

Authors:  Paul K Herman
Journal:  Curr Opin Microbiol       Date:  2002-12       Impact factor: 7.934

Review 7.  Biomaterials surfaces capable of resisting fungal attachment and biofilm formation.

Authors:  Bryan R Coad; Sarah E Kidd; David H Ellis; Hans J Griesser
Journal:  Biotechnol Adv       Date:  2013-11-07       Impact factor: 14.227

8.  Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification.

Authors:  María Eugenia Cabral; Lucía I C Figueroa; Julia I Fariña
Journal:  Rev Iberoam Micol       Date:  2012-10-13       Impact factor: 1.044

9.  Simulating calcium influx and free calcium concentrations in yeast.

Authors:  Jiangjun Cui; Jaap A Kaandorp; Olufisayo O Ositelu; Veronica Beaudry; Alicia Knight; Yves F Nanfack; Kyle W Cunningham
Journal:  Cell Calcium       Date:  2008-09-10       Impact factor: 6.817

10.  High resistance to oxidative stress in the fungal pathogen Candida glabrata is mediated by a single catalase, Cta1p, and is controlled by the transcription factors Yap1p, Skn7p, Msn2p, and Msn4p.

Authors:  Mayra Cuéllar-Cruz; Marcela Briones-Martin-del-Campo; Israel Cañas-Villamar; Javier Montalvo-Arredondo; Lina Riego-Ruiz; Irene Castaño; Alejandro De Las Peñas
Journal:  Eukaryot Cell       Date:  2008-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.